TRAFALGAR INTERNATIONAL, INC. (GCAN) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US3916572023

Price
0.81 USD
Market cap
160,989.96 USD
P/E (2025)
–
P/S (2025)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
44.71 %
Return on assets (ROA)
-40,688.59 %

TRAFALGAR INTERNATIONAL, INC. financials

Fiscal year20242025
Operating income-156,276.00 USD-183,005.00 USD
EBIT-179,041.00 USD-331,612.00 USD
Net income-179,041.00 USD-331,612.00 USD
Diluted EPS – continuing operations0.00 USD0.00 USD

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About TRAFALGAR INTERNATIONAL, INC.

Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors. The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026. The company was founded in 2014 and is based in Miami, Florida.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.